Company / Net Income
Sana Biotechnology, Inc. Net Income History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$266.8M
FY2024
5-year range
-$355.9M / -$266.8M
FY2020-FY2024
Trend
+5.8%
vs FY2023
Sector context
#172 of 216
Health Care
What the data says
Sana Biotechnology, Inc.'s net income of -$267M is lower than 80% of companies in the Health Care sector (FY2024). Net Income has fluctuated over the past 6 years, ranging from -$356M in FY2021 to -$131M in FY2019.
Based on SEC 10-K filings.
-$267M in FY2024.
Remained stable around -$267M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 216This company -$266.8M Sector average $454.3M
▼
-158.7% below sector average
Key checks
Key Insights
- In FY2024, net income increased 5.8% year-over-year.
- Ranks #172 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$266.8M | +5.8% |
| FY2023 | -$283.3M | -5.1% |
| FY2022 | -$269.5M | +24.3% |
| FY2021 | -$355.9M | -24.8% |
| FY2020 | -$285.3M | -118.2% |
| FY2019 | -$130.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026